Gene: C19orf81
Official Full Name: chromosome 19 open reading frame 81provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19140 | C19orf81 Knockout cell line (HCT 116) | Human | C19orf81 | 1:2~1:4 | Negative | Online Inquiry |
KO19141 | C19orf81 Knockout cell line (HEK293) | Human | C19orf81 | 1:3~1:6 | Negative | Online Inquiry |
KO19142 | C19orf81 Knockout cell line (A549) | Human | C19orf81 | 1:3~1:4 | Negative | Online Inquiry |
C19orf81 Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to disrupt the expression of the C19orf81 gene, providing invaluable tools for functional genomics research. By utilizing CRISPR-Cas9 technology, these cell lines exhibit a targeted knockout of the gene, allowing researchers to investigate the biological roles of C19orf81 in various physiological and pathological contexts. This innovation enables precise studies on gene function, cellular signaling pathways, and interactions that are critical in disease mechanisms.
The key function of these cell lines lies in their ability to facilitate the exploration of C19orf81’s involvement in cellular processes such as proliferation, differentiation, and apoptosis. Mechanistically, the knockout process leads to the loss of protein expression attributed to the C19orf81 gene, enabling researchers to observe the resultant phenotypic changes and their implications for cellular behavior. This provides a clearer understanding of the gene's role, particularly in relation to conditions like cancer, neurodegenerative diseases, and other complex disorders.
The scientific importance of C19orf81 Gene Knockout Cell Lines is profound, serving as essential models in both research and clinical settings. They allow for the validation of disease mechanisms and the development of therapeutic strategies, especially in the identification of potential drug targets. Compared to other gene manipulation methods, the CRISPR methodology employed yields higher efficiency and specificity, reducing off-target effects and enhancing the reliability of experimental outcomes.
For researchers and clinicians, these cell lines offer significant advantages, including expedited studies on gene function and disease relevance, as well as the potential to streamline the drug discovery process. The well-characterized nature of these cell lines also allows for reproducibility and consistency, which are critical for advancing scientific inquiry and collaboration.
With a proven track record in genetic engineering and cellular biology, our company stands at the forefront of providing high-quality biological products. Our C19orf81 Gene Knockout Cell Lines not only enable significant advancements in research but also represent our commitment to supporting the scientific community with innovative and reliable tools for exploration.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.